Avaleht › Alzheimeri tõbi › Florida
Alzheimeri tõbi kliinilised uuringud osariigis Florida
51 uuringut haiguse Alzheimeri tõbi jaoks otsivad osalejaid osariigis Florida.
Linnad osariigis Florida
- Orlando25 uuringut
- Miami20 uuringut
- Tampa17 uuringut
- The Villages15 uuringut
- West Palm Beach13 uuringut
- Deltona10 uuringut
- Cape Coral9 uuringut
- Jacksonville8 uuringut
- Boca Raton8 uuringut
- Hollywood7 uuringut
- Naples7 uuringut
- Melbourne7 uuringut
- Hialeah6 uuringut
- Port Saint Lucie6 uuringut
- Ocala6 uuringut
- Doral4 uuringut
- St. Petersburg4 uuringut
- Sarasota3 uuringut
- Homestead3 uuringut
Ametlik uuringutekst (inglise keeles)
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
- Palm Springs Community Health Center, Miami Lakes
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 40–65 · Kõik sood · Uuendatud 30. sept 2026 · NCT07142278A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Boca Raton
- Clinical Site, Deerfield Beach
- Clinical Site, Doral
- ja veel 11
VärbamineFaas 2
Vanused 55–90 · Kõik sood · Uuendatud 30. sept 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Envision Trials LLC, Bonita Springs
- Clinical Research of Brandon, Brandon
- Science Connections LLC, Doral
- ja veel 6
VärbamineFaas 2
Vanused 55 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2602, Bonita Springs
- Nuovida Research Center, Miami
- Local Institution - 1635, Orlando
- ja veel 3
VärbamineFaas 3
Vanused 55–90 · Kõik sood · Uuendatud 28. sept 2026 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- Mayo Clinic Jacksonville, Jacksonville
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT00869817A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- First Choice Neurology - Aventura Neurologic Associates, Aventura
- Galiz Research, Hialeah
- Clincloud, LLC - Viera Office, Melbourne
- ja veel 3
VärbamineFaas 4
Vanused 50 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07633470A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Local Institution - 0003, Bradenton
- Local Institution - 0005, Daytona Beach
- Local Institution - 0007, Naples
- ja veel 1
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–80 · Kõik sood · Uuendatud 24. sept 2026 · NCT07780383A Study of LY3439539 in Participants With Alzheimer's Disease
- K2 Medical Research, Maitland
- Charter Research, Orlando
- AdventHealth Orlando, Orlando
VärbamineFaas 1
Vanused 50–85 · Kõik sood · Uuendatud 24. sept 2026 · NCT07598370Combating Alzheimer's Through Sleep and Exercise
- University of Miami Hospitals, Miami
VärbamineTerved vabatahtlikud oodatud
Vanused 55–80 · Kõik sood · Uuendatud 23. sept 2026 · NCT04855630A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- JEM Research Institute, Atlantis
- VIN - Aventura, Aventura
- Brain Matters Research, Delray Beach
- ja veel 10
VärbamineFaas 2
Vanused 55–85 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589595A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Aqualane Clinical Research- Site Number : 8400001, Naples
- Charter Research - Lady Lake- Site Number : 8400004, The Villages
VärbamineFaas 2
Vanused 55–85 · Kõik sood · Uuendatud 22. sept 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Envision Trials LLC, Bonita Springs
- Arrow Clinical Trials, Daytona Beach
- Local Institution - 1264, Gulf Breeze
- ja veel 9
VärbamineFaas 3
Vanused 55–90 · Kõik sood · Uuendatud 22. sept 2026 · NCT06585787Microbiome in Aging of Gut and Brain
- Department of Neurosurgery and Brain and Spine and Faculty of USF Center for Microbiome Re-search, Microbiomes Institute, Tampa
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. sept 2026 · NCT07799402Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- JEM Research Institute, Atlantis
- Brain Matters Research, Delray Beach
- Neuropsychiatric Research Center of Southwest Florida, Fort Myers
- ja veel 4
VärbamineFaas 2
Vanused 55–80 · Kõik sood · Uuendatud 21. sept 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- JEM Research LLC, Atlantis
- K2 Medical Research-Winter Garden, Clermont
- K2 Medical Research - The Villages, Lady Lake
- ja veel 10
VärbamineFaas 3
Vanused 50–90 · Kõik sood · Uuendatud 21. sept 2026 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Key Clinical Research LLC /ID# 277800, Bradenton
- K2 Medical Research - Clermont /ID# 277859, Clermont
- K2 Medical Research - The Villages /ID# 278290, Lady Lake
- ja veel 3
VärbamineFaas 1/2
Vanused 50–90 · Kõik sood · Uuendatud 18. sept 2026 · NCT07599670Pulsed Electromagnetic Field Treatment With Dementia Patients
- University of Miami, Boca Raton
Värbamine
Vanused 50–100 · Kõik sood · Uuendatud 17. sept 2026 · NCT06862557A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Neuropsychiatric Research Center of Southwest Florida, Fort Myers
- Jacksonville Center for Clinical Research, Jacksonville
- K2 MEDICAL Research THE VILLAGES, Lady Lake
- ja veel 4
VärbamineFaas 3
Vanused 60–85 · Kõik sood · Uuendatud 17. sept 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2648, Aventura
- Envision Trials LLC, Bonita Springs
- Key Clinical Research, Bradenton
- ja veel 6
VärbamineFaas 3
Vanused 55–90 · Kõik sood · Uuendatud 16. sept 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1622, Maitland
- Local Institution - 1631, Maitland
- Flourish Research, Merritt Island
- ja veel 6
VärbamineFaas 3
Vanused 55–90 · Kõik sood · Uuendatud 16. sept 2026 · NCT07011732A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- K2 Medical Research, LLC, Maitland
VärbamineFaas 3
Vanused 55–80 · Kõik sood · Uuendatud 10. sept 2026 · NCT07717411Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Arrow Clinical Trials, Daytona Beach
- ClinCloud, Maitland
- Local Institution - 0007, Maitland
- ja veel 3
VärbamineFaas 2
Vanused 55–90 · Kõik sood · Uuendatud 1. sept 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- JEM Research Institute ( Site 1046), Atlantis
- Neuropsychiatric Research Center of Southwest Florida ( Site 1003), Fort Myers
- K2 Medical Research ( Site 1047), Maitland
- ja veel 10
VärbamineFaas 2
Vanused 50–85 · Kõik sood · Uuendatud 26. aug 2026 · NCT07033494Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- Baptist Health Research Institute, Jacksonville
Värbamine
Vanused 50 ja vanemad · Kõik sood · Uuendatud 24. aug 2026 · NCT07178210A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- K2 Medical Research, LLC, Maitland
- Charter Research, LLC, The Villages
VärbamineFaas 1
Vanused 50–85 · Kõik sood · Uuendatud 24. aug 2026 · NCT06297590AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Comprehensive Center for Brain Health, Boca Raton
- Palm Springs Community Health Center, Miami Lakes
- Alzheimer's Research and Treatment Center (Stuart), Stuart
- ja veel 2
VärbamineFaas 1
Vanused 65–80 · Kõik sood · Uuendatud 21. aug 2026 · NCT07158905A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- JEM Research Institute, Atlantis
- VIN-Julie Schwartzbard, Aventura
- Merritt Island Medical Research, LLC, Merritt Island
- ja veel 3
VärbamineFaas 3
Vanused 60–85 · Kõik sood · Uuendatud 20. aug 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Jacksonville, Jacksonville
- University of Miami, Miami
- Cleveland Clinic Florida, Weston
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 4. aug 2026 · NCT06563895A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- K2 Medical Research The Villages LLC, Lady Lake
- Charter Research, LLC, Orlando
- Headlands Horizons LLC, Orlando
- ja veel 1
VärbamineFaas 1/2
Vanused 35–85 · Kõik sood · Uuendatud 10. juuli 2026 · NCT05462106Low-Dose Radiotherapy for Alzheimer's Disease
- Renaissance Institute of Precision Oncology & Radiosurgery, Winter Park
VärbamineFaas 1/2
Vanused 50 ja vanemad · Kõik sood · Uuendatud 9. juuli 2026 · NCT07693140A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- VIN - Aventura, Aventura
- Bradenton Research Center, Inc., Bradenton
- Finlay Medical Research, Greenacres City
- ja veel 16
VärbamineFaas 3
Vanused 55 ja vanemad · Kõik sood · Uuendatud 7. juuli 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Local Institution - 1401, Naples
VärbamineFaas 3
Vanused 55–90 · Kõik sood · Uuendatud 30. juuni 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Jem Research Institute, Atlantis
- Visionary Investigators Network, Aventura
- K2 Medical Research LLC, Maitland
- ja veel 6
VärbamineFaas 2
Vanused 50–85 · Kõik sood · Uuendatud 26. juuni 2026 · NCT07094516Neurologic Stem Cell Treatment Study
- MD Stem Cells, Coral Springs
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 26. juuni 2026 · NCT02795052A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- K2 Medical Research - The Villages, Lady Lake
- K2 Medical Research, Maitland
- Aqualane Clinical Research, Naples
- ja veel 2
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 45–85 · Kõik sood · Uuendatud 4. juuni 2026 · NCT06657768Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
- University of Miami Department of Neurology, Miami
VärbamineFaas 2
Vanused 55–90 · Kõik sood · Uuendatud 28. mai 2026 · NCT06781333Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
- University of Miami Department of Neurology, Miami
VärbamineFaas 2
Vanused 55–90 · Kõik sood · Uuendatud 28. mai 2026 · NCT07512362[18F]PI-2620 Phase 3 Histopathological Study
- Galiz Research, Hialeah
- K2 Medical Research, Lady Lake
- K2 Medical Research, Maitland
- ja veel 3
VärbamineFaas 3
Vanused 50 ja vanemad · Kõik sood · Uuendatud 22. mai 2026 · NCT05641688Late Onset Alzheimer's Disease
- University of Miami, Miami
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 55 ja vanemad · Kõik sood · Uuendatud 18. mai 2026 · NCT05010603Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
- University of South Florida, Tampa
- University of South Florida, Tampa
VärbamineTerved vabatahtlikud oodatud
Vanused 21 ja vanemad · Kõik sood · Uuendatud 29. apr 2026 · NCT06722352Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.